Dr. Lily Adams is a scientist with hands-on laboratory experience in infectious diseases and biotechnological applications. She holds a Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill, as well as a M.S. in Bioinformatics and B.S. in Biotechnology and Molecular Bioscience from the Rochester Institute of Technology. Dr. Adams’ experience spans from computational biology to molecular virology, including BSL3 and Select Agent research. At Gryphon, she uses her practical skills and knowledge to increase global preparedness for biological pathogens and new developments in biotechnology.

Dr. Mindy James is a microbiologist with a background in biosafety program management. She holds an MS in food science and a PhD in plant pathology, both from Oklahoma State University. Prior to joining Gryphon, she served as the Biosafety Officer at Oklahoma State where she gained expertise in implementation of Federal regulations for research involving biohazardous materials, risk assessment, and BSL3 laboratory operations. At Gryphon, Dr. James focuses on projects related to microbiology, infectious disease, and topics related to biosafety such as gaps in the design and use of PPE.

Anna Muldoon holds a Master of Public Health (MPH) degree from George Washington University and is working on a PhD in Human and Social Dimensions of Science and Technology at Arizona State University. Prior to joining Gryphon, Anna worked at HHS/ASPR in the Biosafety, Biosecurity, and Countering Biological Threats Division, on topics such as International Health Regulations and the Biological Weapons Convention, Potential Pandemic Pathogen Care and Oversight (P3CO), and synthetic DNA guidelines. She is an expert in conspiracy theory studies and a co-author of Covid-19 Conspiracy Theories: QAnon, 5G, the New World Order and Other Viral Ideas. At Gryphon, Anna focuses on biosafety, biosecurity, and infectious disease policy.

Dr. Daniel Greene is a biosecurity researcher in the Biosafety, Biosecurity, and Emerging Technologies practice area at Gryphon. Daniel completed a PhD in Education at Stanford and worked for several years at an education-technology nonprofit before becoming inspired to work on biorisk issues and completing a postdoc at Stanford’s Center for International Security and Cooperation. His interests include using insights from the social and behavioral sciences to improve risk-assessment methods and promote a culture of responsibility among life scientists.

Erin Lauer holds a BS in Immunology and Infectious Disease from Penn State University with a focus in Global Health and honors in Security and Risk Analysis. Since joining Gryphon in 2014, she has applied her interdisciplinary skillset to analyzing various facets of infectious disease risks for federal and international entities, with a focus on laboratory biosafety and biosecurity. She also works on data management and science communications for infectious disease research networks, facilitating widespread use of their data in the research community.

Audrey Cerles graduated from Cornell in biological sciences with a concentration in microbiology and holds an MS in food safety from Michigan State University. Joining Gryphon in 2013, she has supported efforts in various fields, including risk assessments of emerging infectious diseases and emerging biotechnologies. She also worked on a vulnerability assessment of critical food additives and holds a special interest in food and agricultural safety and defense.